Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Hepion Pharmaceuticals's total debt was $299.58K at Sep 30, 2026. For fiscal 2020 it was $0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $299.58K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $176.59K | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $0 | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $832.90K | – |
See a number that looks wrong?